ArticleWorld journal of urology2019

Intravesical BCG treatment causes a long-lasting reduction of recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer.

Tomas Thiel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.